Gender differences in endothelial function in aortas from type 2 diabetic model mice

Journal of Pharmacological Sciences

Volumn 111, Issue 1, 2009, Pages 91-99

  Takenouchi, Yasuhiro ^a   Kobayashi, Tsuneo ^a   Taguchi, Kumiko ^a   Matsumoto, Takayuki ^a   Kamata, Katsuo ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Aorta; Diabetes; Endothelial cell; Gender difference

Indexed keywords

ACETYLCHOLINE; ADIPONECTIN; CHOLESTEROL; CLONIDINE; GLUCOSE; INSULIN; N(G) NITROARGININE; NITROPRUSSIDE SODIUM; NORADRENALIN; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CONSTRICTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; THORACIC AORTA; TRIACYLGLYCEROL BLOOD LEVEL; VASODILATATION;

ADIPONECTIN; ANIMALS; AORTA; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FEMALE; INSULIN; MALE; MICE; MICE, INBRED ICR; PROTO-ONCOGENE PROTEINS C-AKT; RANDOM ALLOCATION; SEX CHARACTERISTICS; TRIGLYCERIDES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 70349510450     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.09133FP     Document Type: Article

References (45)

1. Cohen RA. Role of nitric oxide in diabetic complications. Am J Ther. 2005;12:499-502. (Pubitemid 41689750)
2. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol. 2000;130:963-974.
3. Pieper GM. Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction. Hypertension. 1998;31:1047-1060.
4. Skyrme-Jones RA, O'Brien RC, Luo M, Meredith IT. Endothelial vasodilator function is related to low-density lipoprotein particle size and low-density lipoprotein vitamin E content in type 1 diabetes. J Am Coll Cardiol. 2000;35:292-299. (Pubitemid 30125516)
5. Natali A, Toschi E, Baldeweg S, Casolaro A, Baldi S, Sironi AM, et al. Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels. Eur Heart J. 2005;26:464-471. (Pubitemid 40314762)
6. Kamata K, Kojima S. Characteristics of contractile responses of aorta to norepinephrine in db/db mice. Res Commun Mol Pathol Pharmacol. 1997;96:319-328. (Pubitemid 27329985)
7. Lam TY, Seto SW, Lau YM, Au LS, Kwan YW, Ngai SM, et al. Impairment of the vascular relaxation and differential expression of caveolin-1 of the aorta of diabetic +db/+db mice. Eur J Pharmacol. 2006;546:134-141.
8. Kobayashi T, Taguchi K, Yasuhiro T, Matsumoto T, Kamata K. Impairment of PI3-K/Akt pathway underlies attenuated endothelial function in aorta of type 2 diabetic mouse model. Hypertension. 2004;44:956-962. (Pubitemid 39577428)
9. Takenouchi Y, Kobayashi T, Matsumoto T, Kamata K. Possible involvement of Akt activity in endothelial dysfunction in type 2 diabetic mice. J Pharmacol Sci. 2008;106:600-608. (Pubitemid 351556239)
10. Peach MJ, Loeb AL, Singer HA, Saye J. Endothelium-derived vascular relaxing factor. Hypertension. 1985;7:I94-I100.
11. Moncada S. Nitric oxide in the vasculature: physiology and pathophysiology. Ann N Y Acad Sci. 1997;811:60-67. (Pubitemid 27308315)
12. 2+ mobilization in the aortic endothelium in streptozotocin-induced diabetic and cholesterol-fed mice. Br J Pharmacol. 1998;123,1509-1516.
13. Kuchan MJ, Frangos JA. Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells. Am J Physiol. 1994;266:C628-C636. (Pubitemid 24115734)
14. 2+ mobilization. Circ Res. 1997;81:885-892.
15. Tsukahara H, Gordienko DV, Tonshoff B, Gelato MC, Goligorsky MS. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney Int. 1994;45:598-604. (Pubitemid 24065099)
16. Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension. 2001;37:1199-1208. (Pubitemid 34163570)
17. Altura BM. Sex as a factor influencing the responsiveness of arterioles to catecholamines. Eur J Pharmacol. 1972;21:423-429.
18. Kauser K, Rubanyi GM. Gender difference in bioassayable endothelium-derived nitric oxide from isolated rat aortae. Am J Physiol. 1994;267:H2311-H2317.
19. Matumoto T, Kakami M, Kobayashi T, Kamata K. Gender differences in vascular reactivity to endothelin-1 (1-31) in mesenteric arteries from diabetic mice. Peptides. 2008;29:1338-1346.
20. Takenouchi Y, Kobayashi T, Matsumoto T, Kamata K. Gender differences in age-related endothelial function in the murine aorta. Atherosclerosis. In Press.
21. Sader MA, Celermajer DS. Endothelial function, vascular reactivity and gender differences in the cardiovascular system. Cardiovasc Res. 2002;53:597-604. (Pubitemid 34175252)
22. Haffner SM, Miettinen H, Stern MP. Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men. Diabetologia. 1997;40:711-717. (Pubitemid 27288118)
23. Bolego C, Cignarella A, Zancan V, Pinna C, Zanardo R, Puglisi L. Diabetes abolishes the vascular protective effects of estrogen in female rats. Life Sci. 1999;64:741-749. (Pubitemid 29098968)
24. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979;241:2035-2038.
25. Kannel WB, Wilson PW. Risk factors that attenuate the female coronary disease advantage. Arch Intern Med. 1995;155:57-61.
26. Barrett-Connor EL, Wingard DL. Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study. Am J Epidemiol. 1983;118:489-496.
27. A-receptor and ERK. Br J Pharmacol. 2008;155:974-983.
28. Kobayashi T, Kamata K. IGF-1 receptor or VEGF mRNA expression by chronic high dose insulin-treatment in aorta from control or established diabetic rats. Am J Physiol Heart Circ. 2002;283:H1761-H1768.
29. Kurup S, Bhonede RP. Combined effect of nicotinamide and streptozotocin on diabetic status in partially pancreatectomized adult BALB/c mice. Horm Metab Res. 2000;32:330-334. (Pubitemid 30682684)
30. Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire- Buys D, et al. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes. 1998;47:224-229. (Pubitemid 28079978)
31. Matsumoto T, Wakabayashi K, Kobayashi T, Kamata K. Alterations in vascular endothelial function in the aorta and mesenteric artery in type II diabetic rats. Can J Physiol Pharmacol. 2004;82:175-182. (Pubitemid 38621690)
32. Novelli M, Fabregat ME, Fernandez-Alvarez J, Gomis R, Masiello P. Metabolic and functional studies on isolated islets in a new rat model of type 2 diabetes. Mol Cell Endocrinol. 2001;175:57-66. (Pubitemid 32372543)
33. Kamata K, Kanie N, Inose A. Mechanisms underlying attenuated contractile response of aortic rings to noradrenaline in fructosefed mice. Eur J Pharmacol. 2001;428:241-249. (Pubitemid 33000147)
34. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem. 2003;278:45021-45026. (Pubitemid 37377262)
35. Tan KC, Xu A, Chow WS, Lam MC, Ai VH, Tam SC, et al. Hypoadiponectinemia is associated with impaired endotheliumdependent vasodilation. J Clin Endocrinol Metab. 2004;89:765-769. (Pubitemid 38269891)
36. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, et al. Disruption of adiponectin causes insulin resistance and neointimal formation J Biol Chem. 2002;277:25863-25866.
37. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2002;106:2767-2770. (Pubitemid 35396973)
38. Brüne B, Lapetina EG. Phosphorylation of nitric oxide synthase by protein kinase A. Biochem Biophys Res Commun. 1991;181: 921-926.
39. Bredt DS, Ferris CD, Snyder SH. Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites. J Biol Chem. 1992;267:10976-10981.
40. Ohara Y, Sayegh HS, Yamin JJ, Harrison DG. Regulation of endothelial constitutive nitric oxide synthase by protein kinase C. Hypertension. 1995;25:415-420.
41. Li H, Oehrlein SA, Wallerath T, Ihrig-Biedert I, Wohlfart P, Ulshöfer T, et al. Activation of protein kinase C alpha and/ or epsilon enhances transcription of the human endothelial nitric oxide synthase gene. Mol Pharmacol. 1998;53:630-637. (Pubitemid 28196484)
42. Goldstein BJ, Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab. 2004;89:2563-2568. (Pubitemid 38766332)
43. Motoshima H, Wu X, Mahadev K, Goldstein BJ. Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochem Biophys Res Commun. 2004;315:264-271. (Pubitemid 38183103)
44. Vanhoutte PM, Miller VM. Alpha 2-adrenoceptors and endothelium-derived relaxing factor. Am J Med. 1989;87:1S-5S.
45. Kobayashi T, Kamata K. Effect of insulin treatment on the smooth muscle contractility and endothelium-dependent relaxation in rat aortae from established STZ-induced diabetes. Br J Pharmacol. 1999;127:835-842. (Pubitemid 29295341)